Smac mimetics and innate immune stimuli synergize to promote tumor death
Authors:
Open Access
- 26 January 2014
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 32 (2) , 182-190
Abstract
Synergistic cancer therapies SMAC mimetic compounds synergize with oncolytic viruses and other innate immune stimuli to promote tumor cell death. Smac mimetic compounds (SMC), a class of drugs that sensitize cells to apoptosis by counteracting the activity of inhibitor of apoptosis (IAP) proteins, have proven safe in phase 1 clinical trials in cancer patients. However, because SMCs act by enabling transduction of pro-apoptotic signals, SMC monotherapy may be efficacious only in the subset of patients whose tumors produce large quantities of death-inducing proteins such as inflammatory cytokines. Therefore, we reasoned that SMCs would synergize with agents that stimulate a potent yet safe “cytokine storm.” Here we show that oncolytic viruses and adjuvants such as poly(I:C) and CpG induce bystander death of cancer cells treated with SMCs that is mediated by interferon beta (IFN-β), tumor necrosis factor alpha (TNF-α) and/or TNF-related apoptosis-inducing ligand (TRAIL). This combinatorial treatment resulted in tumor regression and extended survival in two mouse models of cancer. As these and other adjuvants have been proven safe in clinical trials, it may be worthwhile to explore their clinical efficacy in combination with SMCs.Keywords
This publication has 47 references indexed in Scilit:
- Modulation of immune signalling by inhibitors of apoptosisTrends in Immunology, 2012
- Initial testing (stage 1) of LCL161, a SMAC mimetic, by the pediatric preclinical testing programPediatric Blood & Cancer, 2011
- Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of GliomaMolecular Therapy, 2010
- Identification of Genetically Modified Maraba Virus as an Oncolytic RhabdovirusMolecular Therapy, 2010
- Synergistic Interaction Between Oncolytic Viruses Augments Tumor KillingMolecular Therapy, 2010
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomasJournal of Neuro-Oncology, 2008
- Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activationProceedings of the National Academy of Sciences, 2008
- Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAPJournal of the American Chemical Society, 2007
- Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced ApoptosisCancer Cell, 2007